Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and pain empathy in healthy men
IRCT20260509069301N1Phase 3Completed
- Sponsor
- Institute for Cognitive Science Studies
- Start
- May 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, single-blind trial of oxytocin, sponsored by Institute for Cognitive Science Studies. Primary endpoint: Pain empathy. Started May 2026; status: completed.
02
Drugs
oxytocin
Beyond the preview
Go deeper on IRCT20260509069301N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260509069301N1.